Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 41-50 of 171 (Search time: 0.004 seconds).
previous
1
...
2
3
4
5
6
7
8
...
18
next
Item hits:
Preview
Issue Date
Title
Author(s)
2014
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily
Hughes, T.
;
Hochhaus, A.
;
Kantarjian, H.
;
Cervantes, F.
;
Guilhot, F.
;
Niederwieser, D.
;
Le Coutre, P.
;
Rosti, G.
;
Ossenkoppele, G.
;
Lobo, C.
;
Shibayama, H.
;
Fan, X.
;
Menssen, H.
;
Kemp, C.
;
Larson, R.
;
Saglio, G.
2014
Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib
Olshen, A.
;
Tang, M.
;
Cortes, J.
;
Gonen, M.
;
Hughes, T.
;
Branford, S.
;
Quintás-Cardama, A.
;
Michor, F.
2013
BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance
Parker, W.
;
Yeoman, A.
;
Jamison, B.
;
Yeung, D.
;
Scott, H.
;
Hughes, T.
;
Branford, S.
2016
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy
Nievergall, E.
;
Reynolds, J.
;
Kok, C.
;
Watkins, D.
;
Biondo, M.
;
Busfield, S.
;
Vairo, G.
;
Fuller, K.
;
Erber, W.
;
Sadras, T.
;
Grose, R.
;
Yeung, D.
;
Lopez, A.
;
Hiwase, D.
;
Hughes, T.
;
White, D.
2015
KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy
Yeung, D.
;
Tang, C.
;
Vidovic, L.
;
White, D.
;
Branford, S.
;
Hughes, T.
;
Yong, A.
2016
Chronic myeloid leukemia: reminiscences and dreams
Mughal, T.
;
Radich, J.
;
Deininger, M.
;
Apperley, J.
;
Hughes, T.
;
Harrison, C.
;
Gambacorti-Passerini, C.
;
Saglio, G.
;
Cortes, J.
;
Daley, G.
2012
Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells
Wang, J.
;
Hughes, T.
;
Kok, C.
;
Saunders, V.
;
Frede, A.
;
Groot Obbink, K.
;
Osborn, M.
;
Somogyi, A.
;
D'Andrea, R.
;
White, D.
2016
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients
Deininger, M.
;
Hodgson, J.
;
Shah, N.
;
Cortes, J.
;
Kim, D.
;
Nicolini, F.
;
Talpaz, M.
;
Baccarani, M.
;
Müller, M.
;
Li, J.
;
Parker, W.
;
Lustgarten, S.
;
Clackson, T.
;
Haluska, F.
;
Guilhot, F.
;
Kantarjian, H.
;
Soverini, S.
;
Hochhaus, A.
;
Hughes, T.
;
Rivera, V.
;
et al.
2013
Signalling by the βc family of cytokines
Hercus, T.
;
Dhagat, U.
;
Kan, W.
;
Broughton, S.
;
Nero, T.
;
Perugini, M.
;
Sandow, J.
;
D'Andrea, R.
;
Ekert, P.
;
Hughes, T.
;
Parker, M.
;
Lopez, A.
2014
Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinib
Eadie, L.
;
Hughes, T.
;
White, D.
Discover
Author
61
Branford, S.
53
White, D.
35
Hochhaus, A.
22
Kantarjian, H.
22
Radich, J.
22
Saglio, G.
20
Kim, D.
20
Yeung, D.
19
Ross, D.
17
Cortes, J.
.
next >
Subject
90
Humans
65
Pyrimidines
64
Leukemia, Myelogenous, Chronic, B...
55
Piperazines
54
Benzamides
52
Imatinib Mesylate
42
Antineoplastic Agents
40
Fusion Proteins, bcr-abl
38
Protein Kinase Inhibitors
31
Male
.
next >
Date issued
1
2020 - 2022
97
2010 - 2019
64
2000 - 2009
9
1995 - 1999